-
EP1096947
European procedure
Extract from the Register of European Patents
EP About this file: EP1096947
| EP1096947 - TOPICAL DRUG FOR THE TREATMENT OF VIRAL INFECTIONS [Right-click to bookmark this link] | Status | No opposition filed within time limit Status updated on 10.06.2005 Database last updated on 29.06.2024 | Most recent event Tooltip | 10.06.2005 | No opposition filed within time limit | published on 27.07.2005 [2005/30] | Applicant(s) | For all designated states Engelhard Arzneimittel GmbH & Co. KG Herzbergstrasse 3 61138 Niederdorfelden / DE | [2002/49] |
| Former [2001/19] | For all designated states Karl Engelhard Fabrik pharm. Präparate GmbH & Co. KG Sandweg 94 60316 Frankfurt/Main / DE | Inventor(s) | 01 /
RUNKEL, Frank Am Lohberg 10 D-35418 Buseck / DE | [2001/19] | Representative(s) | Weller, Wolfgang, et al Witte, Weller & Partner Patentanwälte mbB Postfach 10 54 62 70047 Stuttgart / DE | [N/P] |
| Former [2001/19] | Weller, Wolfgang, Dr., et al Witte, Weller & Partner Patentanwälte Postfach 105462 70047 Stuttgart / DE | Application number, filing date | 99925030.1 | 22.05.1999 | [2001/19] | WO1999EP03540 | Priority number, date | DE1998123319 | 26.05.1998 Original published format: DE 19823319 | [2001/19] | Filing language | DE | Procedural language | DE | Publication | Type: | A1 Application with search report | No.: | WO9961045 | Date: | 02.12.1999 | Language: | DE | [1999/48] | Type: | A1 Application with search report | No.: | EP1096947 | Date: | 09.05.2001 | Language: | DE | The application published by WIPO in one of the EPO official languages on 02.12.1999 takes the place of the publication of the European patent application. | [2001/19] | Type: | B1 Patent specification | No.: | EP1096947 | Date: | 04.08.2004 | Language: | DE | [2004/32] | Search report(s) | International search report - published on: | EP | 02.12.1999 | Classification | IPC: | A61P31/12, A61P31/22, A61K45/06, A61K31/164, A61K38/08, A61K38/04 | [2004/05] | CPC: |
A61K38/164 (EP);
A61P31/12 (EP);
A61P31/22 (EP)
| C-Set: |
A61K38/164, A61K2300/00 (EP);
A61K38/164, A61K31/44, A61K31/16 (EP) |
| Former IPC [2001/19] | A61K38/16 | Designated contracting states | DE [2001/19] | Title | German: | TOPISCH ANWENDBARES ARZNEIMITTEL ZUR BEHANDLUNG VON VIRUSINFEKTIONEN | [2001/19] | English: | TOPICAL DRUG FOR THE TREATMENT OF VIRAL INFECTIONS | [2001/19] | French: | MEDICAMENT TOPIQUE POUR LE TRAITEMENT D'INFECTIONS VIRALES | [2001/19] | Entry into regional phase | 10.03.2001 | National basic fee paid | 10.03.2001 | Designation fee(s) paid | 10.03.2001 | Examination fee paid | Examination procedure | 23.12.1999 | Request for preliminary examination filed International Preliminary Examining Authority: EP | 10.03.2001 | Examination requested [2001/20] | 05.05.2001 | Amendment by applicant (claims and/or description) | 02.02.2004 | Communication of intention to grant the patent | 13.05.2004 | Fee for grant paid | 13.05.2004 | Fee for publishing/printing paid | Opposition(s) | 06.05.2005 | No opposition filed within time limit [2005/30] | Fees paid | Renewal fee | 10.03.2001 | Renewal fee patent year 03 | 24.05.2002 | Renewal fee patent year 04 | 23.05.2003 | Renewal fee patent year 05 | 25.05.2004 | Renewal fee patent year 06 | Penalty fee | Penalty fee Rule 85a EPC 1973 | 07.02.2001 | DE M01 Fee paid on 10.03.2001 | Penalty fee Rule 85b EPC 1973 | 07.02.2001 | M01 Fee paid on 10.03.2001 |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Cited in | International search | [X]EP0154344 (BRIGHAM DANA [US]) [X] 1,2,4,7-11 * page 1, lines 3-23 * * page 2, lines 19-24 * * page 4, lines 6-12; table 1 * * page 4, line 36 - page 5, line 4 * * page 6, lines 24-36 * * page 14, line 29 - page 15, line 19 * * page 22, lines 15-34; example -; claims 1,2,5-22 *; | [XA]EP0355536 (LOHMANN THERAPIE SYST LTS [DE]) [X] 1,3-6 * page 11; examples 1-8,11; claim 8 * * column 21; examples 19,20 * * column 15, lines 17-26 * * column 5, line 57 - column 6, line 1 * [A] 2,7; | [X]WO9517165 (PROCTER & GAMBLE [US]) [X] 1,4,7 * page 2, line 27 - page 3, line 15; claims 1-3 * * page 4, lines 8-10 * * page 4, lines 18-20 *; | [XA]EP0439042 (HOFFMANN LA ROCHE [CH]) [X] 1,2,4,7,8 * page 2, lines 17-27; example 8; claim 6 * [A] 3,5; | [X]DE2429033 (LUKASCHEK HANS) [X] 1,4,6,7 * claim - *; | [X]WO9629056 (GEBRO BROSCHEK GMBH [AT], et al) [X] 1,3-5,7 * page 5, lines 1-5; claims 1,13 *; | [A]US5624906 (VERMEER ROBERT [US]) [A] 1,3-7 * column 33, line 40 - column 34, line 2 * * column 35, line 65 - column 36, line 21 * * columns 89-90; example 112 * | [A] - VUCINA ET AL, "Uso del Pantenol (Bepantol M.R.) en el Tratamiento del Herpes Zoster", PEDIATRÍA, (1965), vol. 8, no. 2, pages 147 - 150, XP002120615 [A] 1,2,4,7-10 * page 149; table 1 * | [A] - HARTMANN D ET AL, "[Experimental protection with tyrothrizin against herpes simple virus infections in mice]. Schutzversuche mit Tyrothricin an der Herpes -simplex-Virus-infizierten Maus.", ARZNEIMITTEL-FORSCHUNG, (1979) 29 (1) 50-4., XP002120616 [A] 1-3,8-11 |